找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical Management of Acute Lymphoblastic Leukemia; From Bench to Bedsid Mark R. Litzow,Elizabeth A. Raetz Book 2022 Springer Nature Switz

[復(fù)制鏈接]
樓主: Washington
41#
發(fā)表于 2025-3-28 15:26:48 | 只看該作者
Minimal Residual Disease in Acute Lymphoblastic Leukemia: Techniques and Application Post-treatment MRD measured by sensitive methods, including multiparametric flow cytometry and real-time quantitative polymerase chain reaction (RQ-PCR), has been incorporated into clinical risk assignment, resulting in substantially improved outcomes. In addition, a novel molecular method, high-th
42#
發(fā)表于 2025-3-28 22:48:33 | 只看該作者
43#
發(fā)表于 2025-3-28 22:59:36 | 只看該作者
Treatment of Adult B- and T-Cell Acute Lymphoblastic Leukemia: An Overview of Current Treatments andet al., J Clin Oncol, 2012). Conversely, ALL is a challenging disease to treat in adults and has a modest prognosis (Jabbour et al., Cancer, 2015). The treatment paradigm for adult ALL adapted from pediatric regimens comprises combination chemotherapy with cycles of induction, consolidation, mainten
44#
發(fā)表于 2025-3-29 03:50:59 | 只看該作者
Acute Lymphoblastic Leukemia in Infants: A Distinctive, High-Risk Subtype of Childhood Acute Lymphobgene (.-r) on chromosome band 11q23 is a defining cytogenetic feature that occurs in approximately 80% of infants with ALL and is associated with poor prognosis for long-term remission and survival. Infant ALL with .-r is characteristically poorly responsive to chemotherapy and hematopoietic stem ce
45#
發(fā)表于 2025-3-29 10:33:48 | 只看該作者
Treatment of Elderly Patients with Acute Lymphoblastic Leukemia In sharp contrast, intensive pediatric chemotherapy regimens for children and adolescents/young adults (AYAs) achieve long-term disease-free remission rates of 80–90% and 50–70%, respectively. The poor prognosis of older adults with ALL is due to a high incidence of poor prognostic chromosomal and
46#
發(fā)表于 2025-3-29 12:56:51 | 只看該作者
Treatment of Childhood Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia been associated with poor outcome. The introduction of tyrosine kinase inhibitors targeting the BCR-ABL1 fusion protein to multiagent chemotherapy regimens has transformed the standard-of-care treatment approach for pediatric patients with Ph+?ALL, resulting in fewer patients being allocated to all
47#
發(fā)表于 2025-3-29 19:03:30 | 只看該作者
Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia were confronted with a dismal prognosis, they can now expect an outcome similar – or even superior – to other subtypes of ALL. Importantly, these improvements in survival were brought about by an integrated approach in which introduction of TKI early in the therapeutic regimen was complemented by d
48#
發(fā)表于 2025-3-29 21:59:58 | 只看該作者
Treatment of Ph-Like Acute Lymphoblastic Leukemiaith high relapse risk and inferior clinical outcomes. Ph-like ALL was first recognized as having a kinase-activated gene expression profile (GEP) similar to that of Philadelphia chromosome-positive ALL (Ph+ ALL) and frequent . (.) alterations, yet lacking the canonical . oncogene fusion. Advances in
49#
發(fā)表于 2025-3-30 02:59:06 | 只看該作者
Prophylaxis and Treatment of Central Nervous System (CNS) Acute Lymphoblastic Leukemiart to the discovery of the central nervous system (CNS) as a sanctuary site for leukemic blasts and implementation of CNS-directed therapy. With the application of risk-stratified, effective, systemic chemotherapy and prophylactic or treatment dosed CNS-directed interventions including intrathecal c
50#
發(fā)表于 2025-3-30 05:32:53 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-18 04:26
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
礼泉县| 汨罗市| 南投县| 禹城市| 修水县| 泰州市| 台江县| 丹巴县| 治县。| 古丈县| 永仁县| 那坡县| 宣恩县| 东乡县| 昌图县| 彩票| 日土县| 新乡市| 延庆县| 宣威市| 金湖县| 宣汉县| 锡林浩特市| 新营市| 通化市| 信阳市| 临高县| 元谋县| 台湾省| 元氏县| 宝应县| 稷山县| 仪征市| 深州市| 伊金霍洛旗| 汕尾市| 新化县| 逊克县| 迁西县| 眉山市| 恩平市|